'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors

• Asıl Yazarlar: Nan Zhang (Yazar), Changming Zhong (Yazar), Guoxiu Liu (Yazar), Siyu Li (Yazar), Li Lin (Yazar), Namin Wei (Yazar), Yu Song (Yazar), Xiaoqing Wan (Yazar), Yanping Wang (Yazar), Yongyan Wang (Yazar), Wanlin Wu (Yazar), Zhongzhi Qian (Yazar), Huaqiang Zhai (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

BackgroundChinese patent medicines are specialty preparations in China that are produced using traditional prescriptions processed by modern pharmaceutical technology. They contain complex ingredients and much attention is paid to their clinical safety. Demonstrating the clinical safety of Chinese p...